B Lynne Parshall sold $324K of Cytokinetics (CYTK)

Executed Nov 19 2025, disclosed Nov 19 2025, the same day.

Value, as filed

$324K

5,000 sh × $64.73

Executed

Nov 19 2025

the trade date, as filed

Disclosed

Nov 19 2025

0 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

BP B Lynne Parshall Director profile →

B Lynne Parshall (Director) filed 7 Form 4 reports in the trailing twelve months (0 purchases, 7 sales), most often in Ionis Pharmaceuticals, Inc. (IONS). The largest single filing was $414K of IONS (5,000 sh × $82.72, as filed), executed Feb 11.

The name

CYTK

Cytokinetics, Incorporated CYTK · Healthcare · 120 filings in 24 months ticker →

Healthcare · Cytokinetics, Incorporated, a biopharmaceutical company, focuses on discovering, developing, and commercializing novel muscle activators an…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by B Lynne Parshall in CYTK

CYTKSALE Cytokinetics, Incorporated $357K
5,000 sh × $71.48
Exec Sep 1
Filed Sep 1 · 4:51 PM ET CYTKSALE Cytokinetics, Incorporated $370K
5,000 sh × $74.08
Exec Jun 1
Filed Jun 1 · 5:30 PM ET CYTKSALE Cytokinetics, Incorporated $306K
5,000 sh × $61.21
Exec Mar 2
Filed Mar 2 · 5:30 PM ET CYTKSALE Cytokinetics, Incorporated $275K
5,000 sh × $54.92
Exec Sep 9 2024
Filed Sep 9 2024 · 5:30 PM ET